FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the field of pharmaceuticals. The hepatoprotective injection pharmaceutical composition contains phosphatidylcholine, vitamin E, methionine and sodium selenite, as well as the surfactant TWIN-80, the organic pharmacopoeial solvent 2-pyrrolidone, benzyl alcohol and water, from which the micellar form is formed, using the following ratio of substances: phosphatidylcholine 0.24 g, vitamin E 0.02 g, methionine 0.04 g, sodium selenite 0.0011 g, benzyl alcohol 0.1 ml, 2-pyrrolidone 3.5 ml, TWIN-80 0.8 ml, water 5.3 ml.
EFFECT: composition is characterized by low toxicity, the ability to target transport, controlled release in the target area, as well as chemical and physical stability during storage.
1 cl, 38 tbl
Title | Year | Author | Number |
---|---|---|---|
DRUG PREPARATION FOR PREVENTION AND TREATMENT OF HYPOVITAMINOSIS AND NORMALISATION OF METABOLISM IN POULTRY | 2013 |
|
RU2506084C1 |
INJECTION DRUG FORM FOR TREATMENT AND PREVENTION OF LIVER DISEASES IN ANIMALS | 2012 |
|
RU2504347C1 |
FEED ADDITIVES FOR POULTRY | 2016 |
|
RU2660920C2 |
HEPATOPROTECTIVE INJECTION PHARMACEUTICAL COMPOSITION ON THE BASIS OF SILIMARINE AND NANOPARTICLES OF SELENIUM | 2017 |
|
RU2645092C1 |
NATURAL PHOSPHOLIPID AGENT | 2008 |
|
RU2367443C1 |
FEED ADDITIVE FOR RUMINANT ANIMALS BASED ON SELENIUM NANOPARTICLES AND COBALT ASPARAGINATE | 2023 |
|
RU2817251C1 |
HEPATOPROTECTIVE AGENT FROM ALGAE | 2017 |
|
RU2667472C1 |
METHOD FOR PREPARING MAGNET-SENSITIVE LIPID COMPOSITE | 2012 |
|
RU2502505C2 |
AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
BIOCOMPOSITION POSSESSING ANTITOXIC AND ANTI-ADAPTOSIS EFFECT, PROPHYLACTIC BIOLOGICAL SUPPLEMENT BASED ON THEREOF | 2005 |
|
RU2319498C2 |
Authors
Dates
2021-11-29—Published
2020-12-25—Filed